Clinical Trial Result Information

Protocol number:
ML25686
Title of Study:
A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab
Sponsor:
Hoffmann-La Roche
Company division:
Pharmaceutical
Product name:
Avastin
Generic name:
bevacizumab
Therapeutic area:
  • Colorectal Cancer
Clinical study summary:
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.
Phase of development:
III
Date of report:
To be Published

Click here for the protocol registry listing of this trial.